Pediatric Cancers - Solid Tumors
Solid tumors encompass several different forms of pediatric cancers. We have targeted pediatric solid tumors for several reasons:
- By targeting solid tumors we have the opportunity to test new potential agents against several differnt forms of pediatric cancers.
- The treatment options for solid tumor cancers such as pediatric
sarcomas are extremely limited, as few as 30 percent of children
battling the disease survive.
- It is estimated that half of the oncology drugs used to treat
with children are at least 20 years old. In the past
10 years, only one cancer drug has received initial approval for
children.
- There is a lack of private sector research for childhood cancer.
This “research gap” is related to the relatively small
number of children needing treatment for the disease as compared
to the much larger adult population. Today, nearly 80% of the children diagnosed
with cancer become long-term survivors, and the majority of them
are considered cured. With additional effort, the goal of eradicating
ALL childhood cancers – the remaining 20% - is achievable.
|
